JP2019500910A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019500910A5 JP2019500910A5 JP2018555445A JP2018555445A JP2019500910A5 JP 2019500910 A5 JP2019500910 A5 JP 2019500910A5 JP 2018555445 A JP2018555445 A JP 2018555445A JP 2018555445 A JP2018555445 A JP 2018555445A JP 2019500910 A5 JP2019500910 A5 JP 2019500910A5
- Authority
- JP
- Japan
- Prior art keywords
- ebna
- reprogramming
- vector
- cell population
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000008672 reprogramming Effects 0.000 claims 57
- 239000013598 vector Substances 0.000 claims 45
- 210000004027 cell Anatomy 0.000 claims 43
- 108010031111 EBV-encoded nuclear antigen 1 Proteins 0.000 claims 34
- 210000004263 induced pluripotent stem cell Anatomy 0.000 claims 25
- 108090000623 proteins and genes Proteins 0.000 claims 19
- 238000012258 culturing Methods 0.000 claims 16
- 238000000034 method Methods 0.000 claims 12
- 102000040945 Transcription factor Human genes 0.000 claims 11
- 108091023040 Transcription factor Proteins 0.000 claims 11
- 230000010076 replication Effects 0.000 claims 8
- 210000001082 somatic cell Anatomy 0.000 claims 7
- 210000001671 embryonic stem cell Anatomy 0.000 claims 6
- 238000004519 manufacturing process Methods 0.000 claims 6
- 101100257359 Caenorhabditis elegans sox-2 gene Proteins 0.000 claims 5
- 102000000311 Cytosine Deaminase Human genes 0.000 claims 5
- 108010080611 Cytosine Deaminase Proteins 0.000 claims 5
- 101100257363 Mus musculus Sox2 gene Proteins 0.000 claims 5
- 239000004098 Tetracycline Substances 0.000 claims 5
- 102000006601 Thymidine Kinase Human genes 0.000 claims 5
- 108020004440 Thymidine kinase Proteins 0.000 claims 5
- 102000040430 polynucleotide Human genes 0.000 claims 5
- 108091033319 polynucleotide Proteins 0.000 claims 5
- 239000002157 polynucleotide Substances 0.000 claims 5
- 229960002180 tetracycline Drugs 0.000 claims 5
- 229930101283 tetracycline Natural products 0.000 claims 5
- 235000019364 tetracycline Nutrition 0.000 claims 5
- 150000003522 tetracyclines Chemical class 0.000 claims 5
- 108020005091 Replication Origin Proteins 0.000 claims 4
- 230000001276 controlling effect Effects 0.000 claims 4
- 239000000758 substrate Substances 0.000 claims 4
- 101100239628 Danio rerio myca gene Proteins 0.000 claims 3
- 101001139134 Homo sapiens Krueppel-like factor 4 Proteins 0.000 claims 3
- 102100020677 Krueppel-like factor 4 Human genes 0.000 claims 3
- 101150111214 lin-28 gene Proteins 0.000 claims 3
- 230000001105 regulatory effect Effects 0.000 claims 3
- 238000012216 screening Methods 0.000 claims 3
- -1 Nanog Proteins 0.000 claims 2
- 101710126211 POU domain, class 5, transcription factor 1 Proteins 0.000 claims 2
- 241000700605 Viruses Species 0.000 claims 2
- 230000004913 activation Effects 0.000 claims 2
- 230000032823 cell division Effects 0.000 claims 2
- 238000011529 RT qPCR Methods 0.000 claims 1
- 238000003556 assay Methods 0.000 claims 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 210000002950 fibroblast Anatomy 0.000 claims 1
- 230000002496 gastric effect Effects 0.000 claims 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims 1
- 210000003494 hepatocyte Anatomy 0.000 claims 1
- 210000002510 keratinocyte Anatomy 0.000 claims 1
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 claims 1
- 238000013518 transcription Methods 0.000 claims 1
- 230000035897 transcription Effects 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662277784P | 2016-01-12 | 2016-01-12 | |
| US62/277,784 | 2016-01-12 | ||
| PCT/US2017/013229 WO2017123789A1 (en) | 2016-01-12 | 2017-01-12 | Methods and vectors to produce vector free induced pluripotent stem cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019500910A JP2019500910A (ja) | 2019-01-17 |
| JP2019500910A5 true JP2019500910A5 (cg-RX-API-DMAC7.html) | 2020-02-20 |
Family
ID=59311564
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018555445A Pending JP2019500910A (ja) | 2016-01-12 | 2017-01-12 | ベクターを含まない人工多能性幹細胞を作製するための方法およびベクター |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20170226483A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3402496A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2019500910A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20180105670A (cg-RX-API-DMAC7.html) |
| CN (1) | CN108778299A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3010764A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL260452A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017123789A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3010764A1 (en) * | 2016-01-12 | 2017-07-20 | Lonza Walkersville, Inc. | Methods and vectors to produce vector free induced pluripotent stem cells |
| US12247226B2 (en) * | 2017-10-11 | 2025-03-11 | Fate Therapeutics, Inc. | Cellular reprogramming using temporal and transient plasmid vector expression system |
| CN108373998B (zh) * | 2018-02-10 | 2019-08-27 | 安徽中盛溯源生物科技有限公司 | 一种通过蝾螈Oct4将人类血液细胞重编程为iPSC的方法 |
| GB201805683D0 (en) * | 2018-04-05 | 2018-05-23 | Touchlight Ip Ltd | Reprogramming vectors |
| CN112368372A (zh) | 2018-06-18 | 2021-02-12 | 巴尔工业株式会社 | 转化细胞的制备方法 |
| CN109679994B (zh) * | 2018-12-13 | 2021-02-02 | 湖北汇智铭传生物科技股份有限公司 | 通过四环素诱导表达外源基因的游离载体及其构建方法 |
| CA3193977A1 (en) * | 2020-10-02 | 2022-04-07 | Yi-Shin Lai | Improved reprogramming, maintenance and preservation for induced pluripotent stem cells |
| CN114277190B (zh) * | 2021-12-31 | 2024-07-23 | 安徽中盛溯源生物科技有限公司 | 一种hiPSC中外源基因残留检测用特异性DNA片段、引物、试剂盒和检测方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ583435A (en) * | 2007-09-04 | 2011-12-22 | Univ Queensland | A feeder cell-free culture medium and system |
| CA2954948A1 (en) * | 2008-06-04 | 2009-12-10 | Cellular Dynamics International, Inc. | Methods for the production of ips cells using non-viral approach |
| US20120315697A1 (en) * | 2009-02-20 | 2012-12-13 | Ventria Bioscience | Cell Culture Media Containing Combinations of Proteins |
| DK2548950T3 (en) * | 2009-06-05 | 2017-12-11 | Cellular Dynamics Int Inc | Reprogramming of T cells and hematopoietic cells |
| JP5898086B2 (ja) * | 2009-11-04 | 2016-04-06 | セルラー ダイナミクス インターナショナル， インコーポレイテッド | 化学物質を用いるエピソームリプログラミング |
| JP2013530699A (ja) * | 2010-06-15 | 2013-08-01 | セルラー ダイナミクス インターナショナル， インコーポレイテッド | 生物学的応答の調査のための既製の幹細胞モデルの概要 |
| US8765470B2 (en) * | 2010-08-04 | 2014-07-01 | Cellular Dynamics International, Inc. | Reprogramming immortalized B-cells to induced pluripotent stem cells |
| CA2841165A1 (en) * | 2011-07-11 | 2013-01-17 | Cellular Dynamics International, Inc. | Methods for cell reprogramming and genome engineering |
| WO2013177228A1 (en) * | 2012-05-22 | 2013-11-28 | Loma Linda University | Generation of integration/transgene-free stem cells |
| CA2874259C (en) * | 2012-05-23 | 2021-02-09 | Kyoto University | Highly efficient method for establishing induced pluripotent stem cell |
| US10738323B2 (en) * | 2013-07-12 | 2020-08-11 | Cedars-Sinai Medical Center | Generation of induced pluripotent stem cells from normal human mammary epithelial cells |
| KR102670874B1 (ko) * | 2014-03-04 | 2024-05-31 | 페이트 세러퓨틱스, 인코포레이티드 | 개선된 재프로그래밍 방법 및 세포 배양 플랫폼 |
| US20160362705A1 (en) * | 2015-06-12 | 2016-12-15 | Lonza Walkersville, Inc. | Methods for Nuclear Reprogramming Using Synthetic Transcription Factors |
| CN108291206B (zh) * | 2015-09-08 | 2022-07-08 | 富士胶片细胞动力公司 | 干细胞来源的视网膜色素上皮的基于macs的纯化 |
| CN108350429B (zh) * | 2015-10-20 | 2022-02-25 | 富士胶片细胞动力公司 | 用于将多能干细胞定向分化为免疫细胞的方法 |
| CA3010764A1 (en) * | 2016-01-12 | 2017-07-20 | Lonza Walkersville, Inc. | Methods and vectors to produce vector free induced pluripotent stem cells |
| US12247226B2 (en) * | 2017-10-11 | 2025-03-11 | Fate Therapeutics, Inc. | Cellular reprogramming using temporal and transient plasmid vector expression system |
| CN108410823B (zh) * | 2018-03-26 | 2019-11-01 | 安徽中盛溯源生物科技有限公司 | 一种微环游离型载体高效重编程血液细胞生成iPSC的方法 |
-
2017
- 2017-01-12 CA CA3010764A patent/CA3010764A1/en not_active Abandoned
- 2017-01-12 CN CN201780016762.2A patent/CN108778299A/zh active Pending
- 2017-01-12 WO PCT/US2017/013229 patent/WO2017123789A1/en not_active Ceased
- 2017-01-12 KR KR1020187023128A patent/KR20180105670A/ko not_active Withdrawn
- 2017-01-12 JP JP2018555445A patent/JP2019500910A/ja active Pending
- 2017-01-12 US US15/404,960 patent/US20170226483A1/en not_active Abandoned
- 2017-01-12 EP EP17738957.4A patent/EP3402496A4/en not_active Withdrawn
-
2018
- 2018-07-06 IL IL260452A patent/IL260452A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019500910A5 (cg-RX-API-DMAC7.html) | ||
| An et al. | Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells | |
| Saha et al. | Technical challenges in using human induced pluripotent stem cells to model disease | |
| Sauer et al. | Induced pluripotent stem cells as a source of hepatocytes | |
| Xu et al. | Highly efficient derivation of ventricular cardiomyocytes from induced pluripotent stem cells with a distinct epigenetic signature | |
| Strulovici et al. | Human embryonic stem cells and gene therapy | |
| JP2009545302A5 (cg-RX-API-DMAC7.html) | ||
| CN107828826A (zh) | 一种体外高效获得神经干细胞的方法 | |
| Castaño et al. | Generation and characterization of a human iPSC cell line expressing inducible Cas9 in the “safe harbor” AAVS1 locus | |
| Sommer et al. | The evolving field of induced pluripotency: recent progress and future challenges | |
| JP2013534140A5 (cg-RX-API-DMAC7.html) | ||
| Vaseghi et al. | Generation of an inducible fibroblast cell line for studying direct cardiac reprogramming | |
| Lee et al. | Efficient exogenous DNA-free reprogramming with suicide gene vectors | |
| Zhong et al. | Barhl1 is required for the differentiation of inner ear hair cell-like cells from mouse embryonic stem cells | |
| Chakraborty et al. | A robust strategy for negative selection of Cre-loxP recombination-based excision of transgenes in induced pluripotent stem cells | |
| Yu et al. | Induced pluripotent stem cells | |
| Horikiri et al. | SOX10-nano-lantern reporter human iPS cells; a versatile tool for neural crest research | |
| Miura et al. | Generation of primitive neural stem cells from human fibroblasts using a defined set of factors | |
| Ruiz et al. | Generation of a drug-inducible reporter system to study cell reprogramming in human cells | |
| CN102199622B (zh) | 一种将微小核糖核酸簇用于改变细胞命运的方法 | |
| JP2016086744A (ja) | ウイルスベクター、細胞およびコンストラクト | |
| US10724051B2 (en) | Methods for enriching gene-targeted cells | |
| Lin et al. | Reprogramming of chimpanzee fibroblasts into a multipotent cancerous but not fully pluripotent state by transducing iPSC factors in 2i/LIF culture | |
| Kim et al. | Novel RNA viral vectors for chemically regulated gene expression in embryonic stem cells | |
| Daneshvar et al. | Induction of pluripotency in human umbilical cord mesenchymal stem cells in feeder layer-free condition |